Brief: Lipigon Conducts Review Of Drug Development Projects, Takes Cost-Saving Measures
22/12/2025 14:43
Dec 22 (Reuters) - Lipigon Pharmaceuticals AB LPGO.ST: CONDUCTS REVIEW OF COMPANY'S DRUG DEVELOPMENT PROJECTS, TAKES COST-SAVING MEASURES Source text: ID:nBQN6M0xGV Further company coverage: LPGO.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Lipigon Pharmaceuticals AB
See all newsBrief: Nasdaq To Delist Lipigon Pharmaceuticals From First North Growth Market
Brief: Lipigon Expected To Be Removed From Trading On Nasdaq Stockholm On May 18
Brief: Lipigon Proposes To Delist Company From Nasdaq First NGM
Brief: Lipigon Pharmaceuticals Oct-Dec Oper Loss At SEK 7.2 Mln
Brief: Lipigon Pharmaceuticals Aims To Reduce Cost Base By Two-Thirds